[1] | Huang ShuiWen, Liu BaoRong, Chen MingSheng, Lin Chun, Zhou Rui, Yang HuiAn, Jiang XiaoYan, Pan Chen, Li DongLiang. Establishment of a predictive model for early virologic response in previously untreated chronic hepatitis B patients treated with telbivudine[J]. Journal of Clinical Hepatology, 2016, 32(7): 1287-1291. doi: 10.3969/j.issn.1001-5256.2016.07.014 |
[2] | Wang Fang, Quan ZuoHua, Yang XingKun, Kou JunFeng, Yun ShengHao, Cai GuoFang, Zhou XinRen. Influence of antiviral therapy with telbivudine on serum soluble complement receptor type 1 in patients with chronic hepatitis B or liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(6): 1118-1120. doi: 10.3969/j.issn.1001-5256.2016.06.019 |
[3] | Wang RongQi, Nan YueMin. Neutropenia caused by telbivudine in chronic hepatitis B patients: a report of one case[J]. Journal of Clinical Hepatology, 2015, 31(2): 273-274. doi: 10.3969/j.issn.1001-5256.2015.02.031 |
[4] | Guo RuYi, Yu XuePing, Su ZhiJun, Lin ChengZu, Lin ZhiPeng, Lin Qi. Evaluation of telbivudine’s efficacy for treating HBeAg-positive chronic B hepatitis patients and identification of its predictive factors by logistic regression analysis[J]. Journal of Clinical Hepatology, 2013, 29(2): 97-100. |
[5] | Dong XiaoPing. Therapeutic effect of telbivudine combined with Fuzheng Huayu tablets in treatment of liver fibrosis in chronic hepatitis B: a report of 60 cases[J]. Journal of Clinical Hepatology, 2013, 29(9): 689-691. doi: 10.3969/j.issn.1001-5256.2013.09.014 |
[6] | Jiang XiuNong, Fan LingYan, Li DeZhou, Wan Jiong, Ye JingJing. Clinical trial of telbivudine in the treatment of chronic hepatitis B in patients during the third trimester of pregnancy[J]. Journal of Clinical Hepatology, 2013, 29(2): 101-103. |
[7] | Zhang XueHua, Zhu ChuanWu, Luo XiangRong, Chai XiaoZhe. Therapeutic efficacy of telbivudine for treating chronic hepatitis B patients with elevated levels of serum soluble E-selectin[J]. Journal of Clinical Hepatology, 2012, 28(11): 839-840+844. |
[8] | Xie Rong, Jiang JianNing, Su MingHua, Liu ZhiHong, Zhong ShaoHua, He LiXia, Liang YanXiu, Hu JiaGuang, Huang XiaoHong, Guo WenWen, Fu WuDao, Zhu MeiQin, Wang BaoJian. Efficacy and safety of initial telbivudine treatment in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 422-424+427. |
[9] | Zheng YuShan, Sun FengLan, Liu XianHong. Comparative study on the therapeutic effects of telbivudine and entecavir on acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2011, 27(6): 641-642+646. |
[10] | Chen XiaoQin, Yao ZhanCheng, Wu LiPing, Chen MingChun, Zhang YanPing, Wu Yi. Clinical study on telbivudine in preventing mother-to-infant HBV transmission during the late pregnancy[J]. Journal of Clinical Hepatology, 2011, 27(12): 1282-1284. |
[11] | Yao QinJiang, Ma WeiGuo. Therapeutic efficacy of telbivudine in hepatitis B e antigen positive chronic hepatitis B patients with high baseline alanine aminotransferase levels[J]. Journal of Clinical Hepatology, 2011, 27(6): 614-616. |
[12] | Song LiWen, Zhao GuiMing, Cao WuKui, Lu ChengZhen. Meta analysis of the comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(9): 955-961. |
[13] | Wang HaiYan, Wang Yu, Peng XiaoMing, Liu Ya. Recent advancement of telbivudine in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(12): 1320-1322+1326. |
[14] | Zhan GuoQing, Tan HuaBing, Zhang WeiWei, Li RuGui, Xie XingRong, Hu Bo. The factors predicting the efficacy of telbivudine in the treatment of HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(6): 608-610. |
[15] | Jin QingLong, Wang ZhongFeng, Yan HongQing, Niu JunQi. The study of the change in creatine kinase in patients with chronic hepatitis B during the antiviral treatment with Telbivudine and Lamivudine[J]. Journal of Clinical Hepatology, 2011, 27(2): 143-144+156. |
[16] | Zhao WenLi, Wang BaoChun, Huang Fei. Therapeutic effects of 48-week telbivudine treatment in patients with cirrhosis caused by HBV[J]. Journal of Clinical Hepatology, 2011, 27(8): 840-843. |
[17] | Hua JianPing, Ma GuiFeng, Li ChunHui, Li JunMei, Bing YuZhi, Zhang QiuYin. The effect of Telbivudine therapy in patients with decompensated cirrhosis caused by HBV[J]. Journal of Clinical Hepatology, 2010, 26(6): 602-604+607. |
[18] | Zhang WeiWei, Yuan XueHua, Tan HuaBing, Zhan GuoQing, Li RuGui, Du WeiXing. Therapeutic Efficacy of telbivudine with phentolamine on patients with chronic severe hepatits B[J]. Journal of Clinical Hepatology, 2009, 25(6): 418-419. |
[19] | Li Zhi, Yan HongMei, Xue FaXuan, Wang Tong, Liang Qun, Xu Huan, Li ZhangChun. Short-term clinical effect of telbivudine in the treatment chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(6): 420-421+426. |